Drug-Eluting Stents Insights From Invasive Imaging Technologies
Open Access
- 1 January 2009
- journal article
- review article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 73 (8) , 1371-1380
Abstract
Drug-eluting stents (DES) represent a revolutionary technology in their unique ability to provide both mechanical and biological solutions simultaneously to the target lesion. As a result of biological effects from the pharmacological agents and interaction of DES components with the arterial wall, considerable differences exist between DES and conventional bare metal stents (BMS), yet some of the old lessons learned in the BMS era remain clinically significant. In this context, contrast angiography provides very little information about in vivo device properties and their biomechanical effects on the arterial wall. In contrast, current catheter-based imaging tools, such as intravascular ultrasound, optical coherence tomography, and intracoronary angioscopy can offer unique insights into DES through direct assessment of the device and treated vessel in the clinical setting. This article reviews these insights from current DES with particular focus on performance and safety characteristics as well as discussing an optimal deployment technique, based upon findings obtained through the use of the invasive imaging technologies. (Circ J 2009; 73: 1371 - 1380)Keywords
This publication has 63 references indexed in Scilit:
- Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stentsInternational Journal of Cardiology, 2010
- Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery StenosisCirculation: Cardiovascular Interventions, 2009
- One Step Forward and Two Steps Back With Drug-Eluting-StentsJACC: Cardiovascular Imaging, 2009
- Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting StentJACC: Cardiovascular Imaging, 2009
- A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting StentsJACC: Cardiovascular Interventions, 2009
- Six-Month Comparison of Coronary Endothelial Dysfunction Associated With Sirolimus-Eluting Stent Versus Paclitaxel-Eluting StentJACC: Cardiovascular Interventions, 2008
- Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopyHeart, 2007
- The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting StentsThe American Journal of Cardiology, 2007
- Intravascular ultrasound assessment of drug-eluting stent expansionAmerican Heart Journal, 2007
- Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stentAmerican Heart Journal, 2006